PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 1, 2026内科诊疗与进展0 citationsOpen Access

规范化抗感染治疗对慢性肺源性心脏病急性加重期的影响

源于源 于

Key Points

  • To investigate the effectiveness of standardized antiinfection treatment for patients experiencing acute exacerbation of chronic pulmonary heart disease.
  • Selected 100 patients with acute exacerbation of COPD from January 2022 to January 2025.
  • Divided patients into an observation group and a control group, with 50 patients each.
  • The control group received conventional antiinfection treatment, while the observation group received a standardized treatment.
  • Compared clinical symptom improvement time, blood gas analysis changes, and hospitalization duration between groups.
  • The observation group showed faster improvement in clinical symptoms compared to the control group.
  • Improvements in blood gas analysis indices were significantly better in the observation group.
  • The hospitalization duration was shorter for patients in the observation group.

Abstract

目的:探究规范化抗感染治疗对慢性肺源性心脏病急性加重期患者的治疗效果。方法:选取某院2022年 1月-2025年1月收治的100例慢肺心急性加重期患者,随机数字表法分为观察组和对照组各50例。对照组采用常规抗感 染治疗方案,观察组采用规范化抗感染治疗方案。通过对比两组患者的临床症状改善时间、血气分析指标变化以及住 院时间三个指标来评估治疗效果。结果:观察组在临床症状改善时间、血气分析指标改善情况以及住院时间方面均优 于对照组。结论:规范化抗感染治疗能够有效改善慢肺心急性加重期患者的临床症状,优化血气分析指标,缩短住院 时间,提高治疗效果,值得在临床推广应用。

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

源 于 (2025) studied this question.

synapsesocial.com/papers/69cd79e15652765b073a6c16https://doi.org/10.37155/2717-5693-0604-38
Ask AI
Helpful
Bookmark
Share
View Full Paper